Pegasus Asset Management, Inc. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Pegasus Asset Management, Inc. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$80,874
+22.0%
26,9580.0%0.04%
+26.7%
Q2 2023$66,317
+8.8%
26,9580.0%0.03%0.0%
Q1 2023$60,926
-35.2%
26,9580.0%0.03%
-41.2%
Q4 2022$94,083
-90.6%
26,9580.0%0.05%
-91.0%
Q3 2022$998,000
+94.9%
26,9580.0%0.56%
+102.9%
Q2 2022$512,000
-29.7%
26,9580.0%0.28%
-12.0%
Q1 2022$728,000
+19.9%
26,9580.0%0.32%
+26.9%
Q4 2021$607,000
-14.1%
26,9580.0%0.25%
-23.4%
Q3 2021$707,000
-18.1%
26,9580.0%0.32%
-19.2%
Q2 2021$863,000
-9.1%
26,9580.0%0.40%
-16.6%
Q1 2021$949,000
+9.7%
26,9580.0%0.48%
+1.7%
Q4 2020$865,000
-14.7%
26,9580.0%0.47%
-25.4%
Q3 2020$1,014,000
-15.9%
26,9580.0%0.64%
-22.9%
Q2 2020$1,206,00026,9580.82%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders